Boston Scientific (BSX) Long-Term Deferred Tax (2016 - 2025)
Boston Scientific (BSX) has disclosed Long-Term Deferred Tax for 17 consecutive years, with $3.7 billion as the latest value for Q4 2025.
- Quarterly Long-Term Deferred Tax rose 0.55% to $3.7 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.7 billion through Dec 2025, up 0.55% year-over-year, with the annual reading at $3.7 billion for FY2025, 0.55% up from the prior year.
- Long-Term Deferred Tax hit $3.7 billion in Q4 2025 for Boston Scientific, roughly flat from $3.7 billion in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $4.2 billion in Q1 2021 to a low of $3.7 billion in Q4 2024.
- Historically, Long-Term Deferred Tax has averaged $3.9 billion across 5 years, with a median of $3.9 billion in 2023.
- Biggest five-year swings in Long-Term Deferred Tax: grew 0.57% in 2022 and later decreased 4.92% in 2023.
- Year by year, Long-Term Deferred Tax stood at $4.1 billion in 2021, then decreased by 4.83% to $3.9 billion in 2022, then fell by 2.56% to $3.8 billion in 2023, then fell by 4.84% to $3.7 billion in 2024, then increased by 0.55% to $3.7 billion in 2025.
- Business Quant data shows Long-Term Deferred Tax for BSX at $3.7 billion in Q4 2025, $3.7 billion in Q3 2025, and $3.8 billion in Q2 2025.